Advertisement
Mr. Hynes will assume responsibility for Symmetry's medical implant,instrument and case facilities across Europe including the UK, Ireland, Franceand Switzerland. He will also direct the operations of the Company's twoaerospace facilities located in the UK.
Advertisement
Mr. Hynes is a seasoned executive with a twenty year history inoperational management, achieving leadership roles in the planning andimplementation of major programs designed to deliver strategic businessobjectives. Just prior to joining Symmetry, Mr. Hynes was responsible forstrategic management of the total Rolls-Royce PLC operational supply chaincovering all seven Rolls-Royce manufacturing businesses. Prior to Rolls-Royce,he was head of logistics for Land Rover Group Ltd.
Mr. Hynes graduated with a Masters Degree in Business Administration fromWarwick University and attended Fords Lean Manufacturing Academy in Liverpool.
Brian Moore, President and Chief Executive Officer, stated, "We arepleased to appoint John Hynes to lead our European facilities. John is anexcellent addition to our European management team. We believe his strongleadership skills and proven track record in the manufacturing sector will addto our growing strength in the global marketplace. We believe his extensiveexperience in the delivery of major projects, new product launches, businessplanning, strategic development and day-to-day operations will make majorcontributions to our European operations."
About Symmetry Medical Inc.
Symmetry Medical Inc. is a leading independent provider of implants andrelated instruments and cases to the orthopedic device industry. The Companyalso designs, develops and produces these products for companies in othersegments of the medical device market, including arthroscopy, dental,laparoscopy, osteobiologic and endoscopy sectors and provides limitedspecialized products and services to non-healthcare markets, such as theaerospace market.
Forward-Looking Statements
Statements in the press release regarding Symmetry Medical Inc.'sbusiness, which are not historical facts, may be "forward-looking statements"that involve risks and uncertainties, within the safe harbor provisions of thePrivate Securities Litigation Reform Act of 1995. Forward-looking statementsare predictive in nature and are frequently identified by the use of termssuch as "may," "should," "expect," "believe," "estimate," "intend," andsimilar words indicating possible future expectations, events or actions. Suchpredictive statements are not guarantees of future performance, and actualresults could differ materially from our current expectations. Certain factorsthat could cause actual results to differ include: the loss of one or morecustomers; the development of new products or product innovations by ourcompetitors; product liability; changes in management; changes in conditionseffecting the economy, orthopedic device manufacturers or the medical deviceindustry generally; and changes in government regulation of medical devicesand third-party reimbursement practices. We refer you to the "Risk Factors"and "Forward Looking Statements" sections in the Company's most recent AnnualReport on Form 10-K filed with the Securities and Exchange Commission as wellas the Company's other filings with the SEC, which are available on the SEC'sWeb site at www.sec.gov.Investors/Media: Contact: The Ruth Group Symmetry Medical Inc. Nick Laudico/Jason Rando Fred L. Hite (646) 536-7030/7025 Senior Vice President [email protected] Chie
